Table 1.
Examples of the biological effects of (−)-epicatechin as well as (+)-taxifolin and/or (−)-taxifolin that were found in the experimental models and that may be relevant for the treatment of hypertension and viral infection.
| Biological Effects | (−)-Epicatechin | (+)-Taxifolin and/or (−)-Taxifolin |
|---|---|---|
| Antihypertensive | [38,58,59,60,61,62,63,64] | [65,66] |
| Vascular | [38,58,59,67,68,69,70,71] | [66] |
| Cardioprotective | [72,73,74] | [75,76] |
| Antidiabetic, antihyperglycemic, or antidyslipidemic | [77,78,79,80,81] | [82] |
| Hepatoprotective | [79] | [83] |
| Respiratory | [84] | [85] |
| Antiinflammatory | [86,87,88] | [89,90] |
| Improved erythrocyte deformability | [38] | [91] |
| Antiaggregatory, antithrombotic, or anticoagulant | [38,92,93] | [64,94,95,96] |
| Antifibrotic | [84] | [75,97] |
| Antiviral | [13,14] | [17] |